Induction of oral tolerance as treatment or prevention of chronic diseases associatet with Chlamydia pneumoniae infection - Hypothesis

Medical Science Monitor

Volumn 9, Issue 5, 2003, Pages

  Moling, Oswald ^a,b   Mian, Peter ^a  

^a Ospedale Generale   (Italy)

^b Ospedale Generale   (Italy)

Author keywords

Asthma; Atherosclerosis; Chlamydia pneumoniae; Oral tolerance; Reiter's syndrome

Indexed keywords

ANTIBIOTIC AGENT; HEAT SHOCK PROTEIN 60; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; GEOGRAPHY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; PATHOGENESIS; PREVALENCE; REITER SYNDROME; RISK FACTOR;

ADMINISTRATION, ORAL; ANTIGENS, BACTERIAL; AUTOIMMUNITY; CHAPERONIN 60; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNE TOLERANCE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; REITER SYNDROME;

EID: 0038509908     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT: Chlamydia pneumoniae (TWAR). Clin Microbiol Rev, 1995; 8: 451-61
2. Wick G, Perschinka H, Millonig G: Atherosclerosis as an autoimmune disease: an update. Trends Immunol, 2001; 22: 665-9
3. Rook GAW, Stanford JL: Give us this day our daily germs. Immunology Today, 1998; 19: 113-6
4. Birk OH, Gur SL, Elias D et al: The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci, 1999; 96: 5159-63
5. Huittinen T, Hahn D, Anttila T et al: Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J, 2001; 17: 1078-82
6. Moudgil KD, Kim E, Yun OJ et al: Environmental modulation of autoimmune arthritis involves spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol, 2001; 166: 4237-43
7. Kutlin A, Ronlin PM, Hammerschlag MR: Effect of prolonged treatment with azithromycin, clarithromycin, or fevofloxacin or on Chlamydia pneumoniae in a continuous-infection model. Antimicrob Agents Chemother, 2002; 46: 409-12
8. Wells HG: Studies on the chemistry of anaphylaxix (111). Experiments with isolated proteins, especially those of the hen's egg. J Infect Dis, 1911; 9: 147-71
9. Weiner HL: Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest, 2000; 106: 935-7
10. Cobelens PM, Haijnen CJ, Nieuwenhuis EES et al: Treatment of adjuvant-induced arthritis by oral administration of mycobacterial hsp65 during disease. Arthritis Rheum, 2000; 43: 2694-702
11. Maron R, Sukhova GK, Faria AM et al: Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in the aortic arch of low-density lipoprotein receptor-deficient mice. Circulation, 2002; 106: 1599-601
12. Harats D, Yacov N, Gilburd B et al: Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol, 2002; 40: 1333-8
13. Kweon MN, Kiyono H: CD40L in autoimmunity and mucosally induced tolerance. J Clin Invest, 2002; 109: 171-3
14. Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-74
15. Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA, 2002; 288: 2724-31
16. Kol A, Sukhova GK, Lichtmann AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage and tumor necrosis factor-a and matrix metalloproteinase expression. Circulation, 1998; 98: 300-307
17. Xu Q: Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol, 2002; 22: 1547-59
18. Powrie F, Maloy KJ: Regulating the regulators. Science, 2003; 299: 1030-31
19. Zhang X, Izikson L, Liu L, Weiner HL: Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J Immunol, 2001; 167: 4245-53
20. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science, 2003; 299: 1033-6
21. Cobelens PM, Kavelaars A, van der Zee R et al: Dynamics of mycobacterial hsp65 induced T-cell cytokine expression during oral tolerance in adjuvant arthritis. Rheumatol, 2002; 41: 775-9
22. Ulmansky R, Cohen CJ, Szafer F et al: Resistance to adjuvant arthritis is due to protective antibodies against heal shock protein surface epitopes and the induction of IL-10 secretion. J Immunol, 2002; 168: 6463-9
23. Phipps PA, Standford MR, Sun JB et al: Prevention of mucosally induced uveitis with an hsp60-derived peptide linked to cholera toxin B subunit. Eur J Immunol, 2003; 33: 224-32